José
Palacios Calvo
Profesor/a Titular Universidad
Javier
Benítez Ortiz
Publications by the researcher in collaboration with Javier Benítez Ortiz (24)
2023
-
CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study
Cancer, Vol. 129, Núm. 5, pp. 697-713
2020
-
Development and validation of the gene expression predictor of high-grade serous ovarian carcinoma molecular SubTYPE (PrOTYPE)
Clinical Cancer Research, Vol. 26, Núm. 20, pp. 5411-5423
2018
-
Association of p16 expression with prognosis varies across ovarian carcinoma histotypes: an Ovarian Tumor Tissue Analysis consortium study
The journal of pathology. Clinical research, Vol. 4, Núm. 4, pp. 250-261
2017
-
Characterisation of the novel deleterious RAD51C p.Arg312Trp variant and prioritisation criteria for functional analysis of RAD51C missense changes
British Journal of Cancer, Vol. 117, Núm. 7, pp. 1048-1062
-
Dose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer
JAMA oncology, Vol. 3, Núm. 12, pp. e173290
2015
-
Exome sequencing identifies ATP4A gene as responsible of an atypical familial type I gastricneuroendocrine tumour
Human Molecular Genetics, Vol. 24, Núm. 10, pp. 2914-2922
2014
-
VGLL1 expression is associated with a triple-negative basal-like phenotype in breast cancer
Endocrine-Related Cancer, Vol. 21, Núm. 4, pp. 587-599
2013
-
Analysis of DNA repair-related genes in breast cancer reveals CUL4A ubiquitin ligase as a novel biomarker of trabectedin response
Molecular Cancer Therapeutics, Vol. 12, Núm. 4, pp. 530-541
-
DNA copy number profiling reveals extensive genomic loss in hereditary BRCA1 and BRCA2 ovarian carcinomas
British Journal of Cancer, Vol. 108, Núm. 8, pp. 1732-1742
2009
-
Comprehensive characterization of the DNA amplification at 13q34 in human breast cancer reveals TFDP1 and CUL4A as likely candidate target genes
Breast Cancer Research, Vol. 11, Núm. 6
2008
-
Distinct genomic aberration patterns are found in familial breast cancer associated with different immunohistochemical subtypes
Oncogene, Vol. 27, Núm. 22, pp. 3165-3175
-
The molecular pathology of hereditary breast cancer
Pathobiology, Vol. 75, Núm. 2, pp. 85-94
2007
-
Immunohistochemical classification of non-BRCA1/2 tumors identifies different groups that demonstrate the heterogeneity of BRCAX families
Modern Pathology, Vol. 20, Núm. 12, pp. 1298-1306
-
Vimentin and laminin expression is associated with basal-like phenotype in both sporadic and BRCA1-associated breast carcinomas
Journal of Clinical Pathology, Vol. 60, Núm. 9, pp. 1006-1012
2006
-
Caveolin-1 expression is associated with a basal-like phenotype in sporadic and hereditary breast cancer
Breast Cancer Research and Treatment, Vol. 99, Núm. 1, pp. 85-90
-
Histopathology of BRCA1- and BRCA2-associated breast cancer
Critical Reviews in Oncology/Hematology, Vol. 59, Núm. 1, pp. 27-39
-
Pathology and gene expression of hereditary breast tumors associated with BRCA1, BRCA2 and CHEK2 gene mutations
Oncogene, Vol. 25, Núm. 43, pp. 5837-5845
-
Prognostic significance of basal-like phenotype and fascin expression in node-negative invasive breast carcinomas
Clinical Cancer Research, Vol. 12, Núm. 5, pp. 1533-1539
2005
-
ERBB2 and MYC alterations in BRCAI- and BRCA2-associated cancers [2] (multiple letters)
Genes Chromosomes and Cancer
-
Phenotypic characterization of BRCA1 and BRCA2 tumors based in a tissue microarray study with 37 immunohistochemical markers
Breast Cancer Research and Treatment, Vol. 90, Núm. 1, pp. 5-14